| abstract |
A method is provided for using compounds that exhibit combined activities as 5-HT1A active agents and selective serotonin reuptake inhibitors (SSRI’s) to treat sexual dysfunction, particularly premature ejaculation, on an as-needed basis shortly before sexual activity. |